Matinas BioPharma to Present at the Oppenheimer 28th Annual Healthcare Conference
Mar 15, 2018 12:00 pm UTC| Business
BEDMINSTER, N.J., March 15, 2018 -- Matinas BioPharma Holdings, Inc. (NYSE MKT:MTNB), a clinical-stage biopharmaceutical company focused on developing innovative anti-infectives for orphan indications, today announced...
Cellectar Announces Late-Breaking Poster Presentations at AACR 2018 Featuring PDCs and CLR 131
Mar 15, 2018 12:00 pm UTC| Business
MADISON, Wis., March 15, 2018 -- Cellectar Biosciences (Nasdaq:CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer,...
Mar 15, 2018 11:55 am UTC| Business
NEW YORK, March 15, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of NewLink Genetics...
Mar 15, 2018 11:50 am UTC| Business
NEW YORK, March 15, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Bandwidth Inc....
Mar 15, 2018 11:45 am UTC| Business
NEW YORK, March 15, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Golden Ocean...
Mar 15, 2018 11:40 am UTC| Business
NEW YORK, March 15, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of AXT Inc...
Mar 15, 2018 11:35 am UTC| Business
NEW YORK, March 15, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Marlin Business...